Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | SUKUN PHARMA | 15 | ₹21,600 |
| 2 | Schedule 2 | R. S. Enterprises | 18 | ₹36,000 |
| 3 | Schedule 3 | AAP PHARMA | 12 | ₹3,900 |
| 4 | Schedule 4 | SUKUN PHARMA | 10 | ₹1,290 |
| 5 | Schedule 5 | SUKUN PHARMA | 11 | ₹1,344 |
Tender Value
₹43.3 L
EMD Value
Exempted
Closing Date
30 Dec 2025, 12:00 pmClosed
MG TAB
COLLAGEN PEPTIDE 40MGplusSOD HYLURU 30MGplusCHONDROTIN TAB
DAPAGLIFOZIN 5 MG TAB
DEFLAZACORT 6 MG TAB
DESVENLAFAXINE 50 MG TAB
DETTOL 500 ML BOTTLE
DICLOFENAC SPRAY BOTTLE OF 40 GM
DILTIAZEM 30 MG TAB
DILTIAZEM 60 MG TAB
DILTIAZEM 90MG SR TAB
DISODIUM HYDROGEN CITRATE SYRUP
ED HOMATROPINE 2percent WobliqueV
ED BRINZOLAMIDE plus BRIMONIDINE
ED NETARSUDIL 0 point02percent
ED PILOCARPINE
ED PREDNISOLONE 1percent
ENALAPRIL 5 MG TAB
EPLERENONE 25 MG TAB
ESOMEPRAZOLE 20 MG plus DOMPERIDONE 30 MG TAB
ETORICOXCIB 120MG TAB
EVENING PRIMROSE 500 MG TAB
EYE OINT HYPROMELLOSE 2percent HYDROXYPROPYL METHYL CELLULOSE 2percent OCULAR LUBE
FAROPENEM SODIUM 200 MG TAB
FENOFIBRATE 160MG TAB
FEXOFENADINE 120MG TAB
FLUNARIZINE 5MG TAB
FUSIDIC ACID OINTobliqueCREAM
GLICLAZIDE 40 MG TAB
GLIMEPRIDE 1MGTAB
HYDRALAZINE 37 point5 plus ISISORBIDE DINITRATE 20 MG TAB ISOLAZINE
HYDROCORTISONE 5 MG TAB
INJ ERYTHROPOIETIN RECOMBINANT HUMAN 2000 IU
INJ IRON SUCROSE
INSULIN HIGHLY PURIFIED ISOPHANE HUMAN NPH 40IUobliqueML
10 ML INJ
KETOCONAZOLE SHAMPO
LACOSAMIDE 100MG TAB
LACOSAMIDE 50 MG TAB
LEFLUNOMIDE ARAVA 10 MG TAB
LEFLUNOMIDE ARAVA 20 MG TAB
LETROZOLE 2 point5MG TAB
LEVO CARNITINE 500MG METHYCOBA 1500 FOLIC ACID 1 point5 MG NEUROKIND LC S TAB
LEVOSALBUTAMOL 50MCG plus BECLOMETASONE 50MCG INHALER
LEVOSULPIRIDE 75MG plus ESOMEPRAZOLE 40MG CAP
LEVOSULPIRIDE 25 MG TAB
LULICONAZOLE CREAM
MEGESTROL ACETATE 160MG TAB
MESALAMINE DR 800MG TAB
MESALAMINE SUPPOSITORY
METHOTREXATE 15 MG TAB
METHYLPREDNISOLONE 4MG TAB
METOPROLOL SR 25 MG TAB
MICRONISED FLAVONOID 500MG TAB DAFLON
MIRABEGRON 25MG TABobliqueCAP
Mirabegron 50 mg Tab
MIRTAZAPINE 15 MG TAB
MODAFINIL 100 MG TAB
NANO CURCUMIN 500 MG TAB
NICORANDIL 5 MG TAB
8719128
GEM/2025/B/7005763
Two Packet Bid
5 AMINO SALICYLIC ACID 400 MG MESALAMINE
15 days
Jammu And Kashmir; Samba
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹15 L
₹10 L
60%
Exempted
6 Jan 2026
19 Dec 2025
30 Dec 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | 5 AMINO SALICYLIC ACID 400 MG MESALAMINE | NIVoblique01 | 15,000 | Nos | [email protected] | 15 |
| 2 | ACEBROPHYLLINE 200 MG SR | NIVoblique01 | 36,000 | Nos | [email protected] | 15 |
| 3 | ACECLOFENAC 100 plus PARACETAMOL 325 plus CHLOROXAZONE 250 TAB HIFENAC MR | NIVoblique01 | 6,000 | Nos | [email protected] | 15 |
| 4 | ACENOCOUMAROL 1 MG TAB | 11029 | 3,000 | Nos | [email protected] | 15 |
| 5 | ACENOCOUMAROL 2 MG TAB | NIVoblique01 | 2,400 | Nos | [email protected] | 15 |
| 6 | ACOTIAMIDE 100MG TAB | NIVoblique01 | 3,000 | Nos | [email protected] | 15 |
| 7 | ACYCLOVIR 200 MG TAB | 13280 | 600 | Nos | [email protected] | 15 |
| 8 | ALFUZOSIN 10 MG TAB | 12609 | 600 | Nos | [email protected] | 15 |
| 9 | ALOVERA AND VITAMIN E LOTION | NIVoblique01 | 60 | Bott | [email protected] | 15 |
| 10 | ALPHA KETOANALOGUE 200 MG TAB | 11915 | 21,000 | Nos | [email protected] | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8719128.pdf
GEM_BID
1_echs_re-8_appx_a_2025-12-15-21-35-56_49fa808e5f9c28b94d267fb0b06e5e58.pdf
BOQ
boq_item_sample_file_-6_2025-12-15-21-35-56_1af17f8cc6d8afc2bc15d46c937a7883.csv
BOQ
1765817456.xlsx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .